MYC and acute myeloid leukemia: Our study focuseson DF2, which is involved in multiple types of cancer, including prostatecancer, MYC-driven breast cancer, and acute myeloid leukemia (AML). This makes DF2 a highly attractive target fordrug discovery and is gaining more and more attention.